Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Radium Chemical Company was a prominent American firm involved in the processing, distribution, and leasing of radium for medical and industrial applications during the early to mid-20th century. Originally established as the sales division of the Standard Chemical Company, it became a leading supplier of radium needles, plaques, and radon seeds used in brachytherapy for cancer treatment. The company is historically significant for its role in the early commercialization of radiopharmaceuticals and medical devices in the United States. Its operations eventually centered in Woodside, New York, where it maintained a manufacturing and storage facility. The company ceased operations in the late 1980s following a major environmental crisis that led to the site being designated as an EPA Superfund location. Its legacy is often studied in the context of early radiation safety standards and the evolution of oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Radium Chemical Company.